Search
Now showing items 1-3 of 3
Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants
Hehlmann, R. et al. (2017)
Wissenschaftlicher Artikel
Safety and efficacy of imatinib in CML over a period of 10 years: data from the randomized CML-study IV
Kalmanti, L. et al. (2015)
Wissenschaftlicher Artikel
Early molecular and cytogenetic response is predictive for long-term progression-free and overall survival in chronic myeloid leukemia (CML)
Hanfstein, B. et al. (2012)
Wissenschaftlicher Artikel